Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Real-time Diagnosis of Diminutive Colorectal Polyps Using AI (COMET-OPTICAL)

29. april 2022 opdateret af: Maastricht University Medical Center

Real Time Computer-aided Diagnosis (CADx) of Diminutive Colorectal Polyps Using Artificial Intelligence

Correct endoscopic prediction of the histopathology and differentiation between benign, pre-malignant, and malignant colorectal polyps (optical diagnosis) remains difficult. Artificial intelligence has great potential in image analysis in gastrointestinal endoscopy. Aim of this study is to investigate the real-time diagnostic performance of AI4CRP for the classification of diminutive colorectal polyps, and to compare it with the real-time diagnostic performance of commercially available CADx systems.

Studieoversigt

Status

Rekruttering

Betingelser

Intervention / Behandling

Detaljeret beskrivelse

Correct endoscopic prediction of the histopathology and differentiation between benign, pre-malignant, and malignant colorectal polyps (optical diagnosis) remains difficult. Despite additional training, even experienced endoscopists continue to fail meeting international thresholds set for safe implementation of treatment strategies based on optical diagnosis.

Multiple machine learning techniques - computer-aided diagnosis (CADx) systems - have been developed for applications in medical imaging within colonoscopy and can improve endoscopic classification of colorectal polyps.

Aim of this study is to explore the feasibility of the workflow using AI4CRP (a CNN based CADx system) real-time in the endoscopy suite, and to investigate the real-time diagnostic performance of AI4CRP for the diagnosis of diminutive (<5mm) colorectal polyps. Secondary, the real-time performance of commercially available CADx systems will be investigated and compared with AI4CRP performance.

Undersøgelsestype

Observationel

Tilmelding (Forventet)

105

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiekontakt

Undersøgelse Kontakt Backup

Studiesteder

  • Holland
    • Limburg
    • Noord-Brabant
      • Eindhoven, Noord-Brabant, Holland, 5623 EJ
        • Afsluttet
        • Catharina Ziekenhuis Eindhoven

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

18 år og ældre (Voksen, Ældre voksen)

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Alle

Prøveudtagningsmetode

Ikke-sandsynlighedsprøve

Studiebefolkning

Patient receiving a colonoscopy because of regular care will be considered eligible for inclusion if at least one diminutive colorectal polyp is encountered during the colonoscopy. Patients receive an endoscopic procedure in the context of the Dutch national screening program, because of gastrointestinal symptoms, or because of follow-up of previously diagnosed bowel diseases.

Beskrivelse

Inclusion Criteria:

  • Age >18 years;
  • Patients with at least one colorectal polyps encountered during colonoscopy;
  • Patients referred for a colonoscopy by the Dutch bowel cancer screening program, patients undergoing a colonoscopy for endoscopic surveillance, or patients undergoing a colonoscopy because of complaints;
  • Written informed consent.

Exclusion Criteria:

  • Patients with prior history of inflammatory bowel diseases (IBD) or polyposis syndromes;
  • Patients with inadequate bowel preparations after adequate washing, suctioning, and cleaning manoeuvres have been performed by the endoscopist;
  • Patients undergoing an emergency colonoscopy;
  • Written objection in the patient file for participation in scientific research.

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

Kohorter og interventioner

Gruppe / kohorte
Intervention / Behandling
Gastroenterology patients

Patient receiving a colonoscopy because of regular care will be considered eligible for inclusion if at least one diminutive colorectal polyp is encountered during the colonoscopy. Patients receive an endoscopic procedure in the context of the Dutch national screening program, because of gastrointestinal symptoms, or because of follow-up of previously diagnosed bowel diseases.

Colonoscopies will be executed using Fujifilm endoscopy systems (Fujifilm® Corporation, Tokyo, Japan), using Pentax endoscopy systems (Pentax Medical®, Hamburg, Germany), and using Olympus endoscopy systems (Olympus®, Tokyo, Japan).
Enhed: Computer-aided diagnosis (CADx) systems
  • AI4CRP (artificial intelligence for colorectal polyps), a CNN based computer-aided diagnosis system for diagnosis of colorectal polyps (COMET-OPTICAL research group);
  • CAD EYE, a computer-aided diagnosis system for diagnosis of colorectal polyps (Fujifilm® Corporation, Tokyo, Japan).
Andre navne:
  • AI4CRP, artificial intelligence for colorectal polyps (COMET-OPTICAL research group)
  • CAD EYE (Fujifilm® Corporation, Tokyo, Japan)

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Technical feasibility of real-time use of AI4CRP.
Tidsramme: 6 months
The technical feasibility of real-time use of AI4CRP in the endoscopy suite regarding a proper reception of the video output from the local endoscopy processor towards AI4CRP (in high definition quality, without any delays in time).
6 months
User interface feasibility of real-time use of AI4CRP.
Tidsramme: 6 months
The user interface feasibility of real-time use of AI4CRP in the endoscopy suite regarding a correct alignment of the user interface of AI4CRP with the video output from the local endoscopy system (resizing image pixels and anonymization).
6 months
The diagnostic accuracy of AI4CRP per image modality (HDWL, BLI, LCI, i-scan).
Tidsramme: 1 year
The real-time diagnostic accuracy of AI4CRP per image modality (HDWL, BLI, LCI, i-scan). Diagnostic accuracy defined as the percentage of correctly optically diagnosed colorectal polyps.
1 year
The sensitivity of AI4CRP per image modality (HDWL, BLI, LCI, i-scan).
Tidsramme: 1 year
The real-time sensitivity of AI4CRP per image modality (HDWL, BLI, LCI, i-scan).
1 year
The specificity of AI4CRP per image modality (HDWL, BLI, LCI, i-scan).
Tidsramme: 1 year
The real-time specificity of AI4CRP per image modality (HDWL, BLI, LCI, i-scan).
1 year
The negative predictive value of AI4CRP per image modality (HDWL, BLI, LCI, i-scan).
Tidsramme: 1 year
The real-time negative predictive value of AI4CRP per image modality (HDWL, BLI, LCI, i-scan).
1 year
The positive predictive value of AI4CRP per image modality (HDWL, BLI, LCI, i-scan).
Tidsramme: 1 year
The real-time positive predictive value of AI4CRP per image modality (HDWL, BLI, LCI, i-scan).
1 year
The Area Under ROC Curve (AUC) of AI4CRP per image modality (HDWL, BLI, LCI, i-scan).
Tidsramme: 1 year
The real-time Area Under ROC Curve (AUC) of AI4CRP per image modality (HDWL, BLI, LCI, i-scan).
1 year

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
The diagnostic accuracy of AI4CRP per polyp.
Tidsramme: 1 year
The real-time diagnostic accuracy of AI4CRP per polyp (comprising the combination of different imaging modalities).
1 year
The sensitivity of AI4CRP per polyp.
Tidsramme: 1 year
The real-time sensitivity of AI4CRP per polyp (comprising the combination of different imaging modalities).
1 year
The specificity of AI4CRP per polyp.
Tidsramme: 1 year
The real-time specificity of AI4CRP per polyp (comprising the combination of different imaging modalities).
1 year
The negative predictive value of AI4CRP per polyp.
Tidsramme: 1 year
The real-time negative predictive value of AI4CRP per polyp (comprising the combination of different imaging modalities).
1 year
The positive predictive value of AI4CRP per polyp.
Tidsramme: 1 year
The real-time positive predictive value of AI4CRP per polyp (comprising the combination of different imaging modalities).
1 year
The Area Under ROC Curve (AUC) of AI4CRP per polyp.
Tidsramme: 1 year
The real-time Area Under ROC Curve (AUC) of AI4CRP per polyp (comprising the combination of different imaging modalities).
1 year
The diagnostic accuracy of CAD EYE in BLI mode, per polyp.
Tidsramme: 1 year
The real-time diagnostic accuracy of CAD EYE in BLI mode, per polyp.
1 year
The sensitivity of CAD EYE in BLI mode, per polyp.
Tidsramme: 1 year
The real-time sensitivity of CAD EYE in BLI mode, per polyp.
1 year
The specificity of CAD EYE in BLI mode, per polyp.
Tidsramme: 1 year
The real-time specificity of CAD EYE in BLI mode, per polyp.
1 year
The negative predictive value of CAD EYE in BLI mode, per polyp.
Tidsramme: 1 year
The real-time negative predictive value of CAD EYE in BLI mode, per polyp.
1 year
The positive predictive value of CAD EYE in BLI mode, per polyp.
Tidsramme: 1 year
The real-time positive predictive value of CAD EYE in BLI mode, per polyp.
1 year
The Area Under ROC Curve (AUC) of CAD EYE in BLI mode, per polyp.
Tidsramme: 1 year
The real-time Area Under ROC Curve (AUC) of CAD EYE in BLI mode, per polyp.
1 year
The diagnostic accuracy of AI4CRP per patient.
Tidsramme: 1 year
The real-time diagnostic accuracy of AI4CRP per patient (in case of multiple polyps per patient).
1 year
The diagnostic accuracy of CAD EYE per patient.
Tidsramme: 1 year
The real-time diagnostic accuracy of CAD EYE per patient (in case of multiple polyps per patient).
1 year
The localization score of AI4CRP.
Tidsramme: 1 year
The localization score of AI4CRP regarding the number of images in which the heatmap produced by AI4CRP pointed out the area of interest (scale: correct, incorrect, or partly correct area of interest).
1 year
The difference in diagnostic accuracy of endoscopists per polyp before and after AI.
Tidsramme: 1 year
The difference in real-time diagnostic accuracy of endoscopists per polyp before and after AI.
1 year
The difference in sensitivity of endoscopists per polyp before and after AI.
Tidsramme: 1 year
The difference in real-time sensitivity of endoscopists per polyp before and after AI.
1 year
The difference in specificity of endoscopists per polyp before and after AI.
Tidsramme: 1 year
The difference in real-time specificity of endoscopists per polyp before and after AI.
1 year
The difference in negative predictive value of endoscopists per polyp before and after AI.
Tidsramme: 1 year
The difference in real-time negative predictive value of endoscopists per polyp before and after AI.
1 year
The difference in positive predictive value of endoscopists per polyp before and after AI.
Tidsramme: 1 year
The difference in real-time positive predictive value of endoscopists per polyp before and after AI.
1 year
The agreement in surveillance interval based on optical diagnosis and histopathology.
Tidsramme: 1 year
The agreement in surveillance interval based on optical diagnosis of diminutive colorectal polyps and histopathology of small and large colorectal polyps, compared to the surveillance interval based on histopathology of all colorectal polyps (diminutive, small, and large).
1 year

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Sponsor

Maastricht University Medical Center

Samarbejdspartnere

Catharina Ziekenhuis Eindhoven
Eindhoven University of Technology

Efterforskere

  • Ledende efterforsker: Erik Schoon, Prof Dr MD, Maastricht Universitair Medisch Centrum

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

20. august 2021

Primær færdiggørelse (Forventet)

1. september 2022

Studieafslutning (Forventet)

1. december 2022

Datoer for studieregistrering

Først indsendt

31. marts 2022

Først indsendt, der opfyldte QC-kriterier

21. april 2022

Først opslået (Faktiske)

27. april 2022

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

5. maj 2022

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

29. april 2022

Sidst verificeret

1. april 2022

Mere information

Begreber relateret til denne undersøgelse

Nøgleord

Yderligere relevante MeSH-vilkår

Andre undersøgelses-id-numre

  • METC2021-3036

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

UBESLUTET

IPD-planbeskrivelse

A data sharing plan is not yet decided on.

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Abonner